Cargando…
Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3
BACKGROUND: This study was aimed to investigate the regulatory role of microRNA-210 (miRNA-210) on the progression of liver cancer and Hepatitis B virus (HBV)-associated liver cancer. METHODS: The expression of miRNA-210 was detected in liver tissues of HBV-associated cirrhosis and liver cancer, and...
Autores principales: | Li, Xiaojie, Yuan, Mei, Song, Lu, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059654/ https://www.ncbi.nlm.nih.gov/pubmed/32138690 http://dx.doi.org/10.1186/s12881-020-0974-9 |
Ejemplares similares
-
The role of microRNAs in liver cancer progression
por: Huang, S, et al.
Publicado: (2011) -
MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen
por: Tagscherer, Katrin E., et al.
Publicado: (2016) -
MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2)
por: Geng, Xiang, et al.
Publicado: (2021) -
Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness
por: Xie, Ying, et al.
Publicado: (2018) -
MicroRNA and liver cancer
por: Onishi, Masaya, et al.
Publicado: (2020)